DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United Kingdom
  • /
  • Household
Author Program NEWCreate Narrative
RKT logo

Reckitt Benckiser Group plc Stock Price

LSE:RKT Community·UK£32.1b Market Cap
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 111 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

RKT Share Price Performance

UK£50.58
-9.36 (-15.61%)
​
UK£61.82
Fair Value
UK£50.58
-9.36 (-15.61%)
18.2% undervalued intrinsic discount
UK£61.82
Fair Value
Price UK£50.58
AnalystConsensusTarget UK£61.82
Wed, 24 Jun 26
Fair ValueUK£61.82
Share Pricen/a

RKT Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value UK£61.82 18.2% undervalued intrinsic discount

Analyst Commentary Highlights Mixed Views as Reckitt Benckiser Updates Guidance and Maintains Valuation

0users have liked this narrative
1users have commented on this narrative
67users have followed this narrative
RKT logo
Reckitt Benckiser Group
18.2% undervalued intrinsic discount

Analyst Commentary Highlights Mixed Views as Reckitt Benckiser Updates Guidance and Maintains Valuation

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 24 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
RKT logo

RKT: Future Returns Will Rely On Resilient Margins And Share Repurchases

Fair Value: UK£61.82 18.2% undervalued intrinsic discount
67 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Very undervalued established dividend payer.

3 Risks
5 Rewards
View Full Analysis

Reckitt Benckiser Group plc Key Details

UK£13.6b

Revenue

UK£5.5b

Cost of Revenue

UK£8.1b

Gross Profit

UK£5.2b

Other Expenses

UK£2.9b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
4.55
59.57%
21.19%
174.5%
View Full Analysis

About RKT

Founded
1819
Employees
36200
CEO
Kristoffer Licht
WebsiteView website
www.reckitt.com

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Recent RKT News & Updates

Recent updates

No updates

Reckitt Benckiser Group plc Competitors

ULVR logo

Unilever

Symbol: LSE:ULVR
Market cap: UK£98.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide